Vitamin K-dependent clotting factors — Drug Target

All drugs that target Vitamin K-dependent clotting factors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Anticoagulant

Phase 2 pipeline (1)

• Anticoagulation treatment. · Samsung Medical Center · Anticoagulant · Cardiovascular
  Anticoagulation via inhibition of vitamin K-dependent clotting factors